InsidersTradesSigma
Track the 新天药业 stock price and the full management transaction log of the company, a listed equity based in China. Shares are quoted on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 新天药业 has published 9 reports. Market capitalisation: €1.7bn. The latest transaction was disclosed on 18 December 2025 (Sale). Among the most active insiders: 陈珏蓉. Every trade is openly available.
9
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€3m
9 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 21,799 of 29,063 companies
34.5
score / 100
Value31
Quality38
FCF yld1.8%
Earn yld0.5%
EV/EBITDA36.1x
ROE0.7%
Gross mgn72%
Net mgn1.2%
Debt/EBITDA10.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 18 December 2025
Declarations9 total
2,190,500 sharesA股XSHESZSE:273000000052638400
9 of 9 declarations
关于 新天药业
新天药业是一家在XSHE市场上市的健康和制药公司。它专注于创新药物的开发和生产。